Literature DB >> 28527699

AT1 receptor signaling pathways in the cardiovascular system.

Tatsuo Kawai1, Steven J Forrester1, Shannon O'Brien2, Ariele Baggett1, Victor Rizzo1, Satoru Eguchi3.   

Abstract

The importance of the renin angiotensin aldosterone system in cardiovascular physiology and pathophysiology has been well described whereas the detailed molecular mechanisms remain elusive. The angiotensin II type 1 receptor (AT1 receptor) is one of the key players in the renin angiotensin aldosterone system. The AT1 receptor promotes various intracellular signaling pathways resulting in hypertension, endothelial dysfunction, vascular remodeling and end organ damage. Accumulating evidence shows the complex picture of AT1 receptor-mediated signaling; AT1 receptor-mediated heterotrimeric G protein-dependent signaling, transactivation of growth factor receptors, NADPH oxidase and ROS signaling, G protein-independent signaling, including the β-arrestin signals and interaction with several AT1 receptor interacting proteins. In addition, there is functional cross-talk between the AT1 receptor signaling pathway and other signaling pathways. In this review, we will summarize an up to date overview of essential AT1 receptor signaling events and their functional significances in the cardiovascular system.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADAM17; Angiotensin II; EGF receptor; Endothelial cell; Signal transduction; Vascular smooth muscle cell

Mesh:

Substances:

Year:  2017        PMID: 28527699      PMCID: PMC5607088          DOI: 10.1016/j.phrs.2017.05.008

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  171 in total

1.  Endothelial dysfunction: the role and impact of the renin-angiotensin system.

Authors:  T F Lüscher
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.

Authors:  Haruhiko Ohtsu; Mizuo Mifune; Gerald D Frank; Shuichi Saito; Tadashi Inagami; Shokei Kim-Mitsuyama; Yoh Takuwa; Terukatsu Sasaki; Jeffrey D Rothstein; Hiroyuki Suzuki; Hidekatsu Nakashima; Elethia A Woolfolk; Evangeline D Motley; Satoru Eguchi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-30       Impact factor: 8.311

Review 3.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

4.  Rap1b in smooth muscle and endothelium is required for maintenance of vascular tone and normal blood pressure.

Authors:  Sribalaji Lakshmikanthan; Bartosz J Zieba; Zhi-Dong Ge; Ko Momotani; Xiaodong Zheng; Hayley Lund; Mykhaylo V Artamonov; Jason E Maas; Aniko Szabo; David X Zhang; John A Auchampach; David L Mattson; Avril V Somlyo; Magdalena Chrzanowska-Wodnicka
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-01       Impact factor: 8.311

5.  ATRAP, novel AT1 receptor associated protein, enhances internalization of AT1 receptor and inhibits vascular smooth muscle cell growth.

Authors:  T Cui; H Nakagami; M Iwai; Y Takeda; T Shiuchi; K Tamura; L Daviet; M Horiuchi
Journal:  Biochem Biophys Res Commun       Date:  2000-12-29       Impact factor: 3.575

Review 6.  Recent progress in signal transduction research of the angiotensin II type-1 receptor: protein kinases, vascular dysfunction and structural requirement.

Authors:  Hiroyuki Suzuki; Evangeline D Motley; Gerald D Frank; Hirotoshi Utsunomiya; Satoru Eguchi
Journal:  Curr Med Chem Cardiovasc Hematol Agents       Date:  2005-10

7.  Notch transcriptional control of vascular smooth muscle regulatory gene expression and function.

Authors:  Sanchita Basu; Dinesh Kumar Srinivasan; Ke Yang; Hema Raina; Suhanti Banerjee; Rongli Zhang; Steven A Fisher; Aaron Proweller
Journal:  J Biol Chem       Date:  2013-03-12       Impact factor: 5.157

8.  Effects of cardiac overexpression of the angiotensin II type 2 receptor on remodeling and dysfunction in mice post-myocardial infarction.

Authors:  Jiang Xu; Ying Sun; Oscar A Carretero; Liping Zhu; Pamela Harding; Edward G Shesely; Xiangguo Dai; Nour-Eddine Rhaleb; Edward Peterson; Xiao-Ping Yang
Journal:  Hypertension       Date:  2014-04-14       Impact factor: 10.190

9.  Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction.

Authors:  Chunyan Hu; Ko-Ting Lu; Masashi Mukohda; Deborah R Davis; Frank M Faraci; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2015-11-03       Impact factor: 3.107

10.  Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice.

Authors:  Debra L Rateri; Jessica J Moorleghen; Victoria Knight; Anju Balakrishnan; Deborah A Howatt; Lisa A Cassis; Alan Daugherty
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more
  48 in total

1.  Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.

Authors:  Yongzhen Zhao; Heng Zeng; Bo Liu; Xiaochen He; Jian-Xiong Chen
Journal:  Am J Physiol Renal Physiol       Date:  2020-07-27

2.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

3.  Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody.

Authors:  Laura M Wingler; Conor McMahon; Dean P Staus; Robert J Lefkowitz; Andrew C Kruse
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 4.  Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.

Authors:  Guanghong Jia; Annayya R Aroor; Michael A Hill; James R Sowers
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

Review 5.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

Review 6.  Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.

Authors:  Mohammed Alqinyah; Shelley B Hooks
Journal:  Cell Signal       Date:  2017-10-16       Impact factor: 4.315

7.  Atorvastatin reverses the dysfunction of human umbilical vein endothelial cells induced by angiotensin II.

Authors:  Haiming Dang; Bangrong Song; Ran Dong; Hongjia Zhang
Journal:  Exp Ther Med       Date:  2018-10-11       Impact factor: 2.447

8.  PKCδ Mediates Mineralocorticoid Receptor Activation by Angiotensin II to Modulate Smooth Muscle Cell Function.

Authors:  Qing Lu; Ana P Davel; Adam P McGraw; Sitara P Rao; Brenna G Newfell; Iris Z Jaffe
Journal:  Endocrinology       Date:  2019-09-01       Impact factor: 4.736

9.  Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats.

Authors:  Alynne Carvalho-Galvão; Blessing Ogunlade; Jiaxi Xu; Cristiane R A Silva-Alves; Leônidas G Mendes-Júnior; Drielle D Guimarães; Josiane C Cruz; Thyago M Queiroz; Camille M Balarini; Valdir A Braga; Catalin M Filipeanu; Eric Lazartigues; Maria do Socorro de França-Silva
Journal:  Clin Sci (Lond)       Date:  2018-07-23       Impact factor: 6.124

Review 10.  Renin angiotensin system and its role in biomarkers and treatment in gliomas.

Authors:  Alexander Perdomo-Pantoja; Sonia Iliana Mejía-Pérez; Liliana Gómez-Flores-Ramos; Montserrat Lara-Velazquez; Cordelia Orillac; Juan Luis Gómez-Amador; Talia Wegman-Ostrosky
Journal:  J Neurooncol       Date:  2018-02-16       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.